Thirty-Day Readmissions after Transcatheter Aortic Valve Replacement in the United States: Insights from the Nationwide Readmissions Database

Dhaval Kolte, Sahil Khera, M. Rizwan Sardar, Neil Gheewala, Tanush Gupta, Saurav Chatterjee, Andrew Goldsweig, Wilbert S. Aronow, Gregg C. Fonarow, Deepak L. Bhatt, Adam B. Greenbaum, Paul C. Gordon, Barry Sharaf, J. Dawn Abbott

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Abstract

Background - Readmissions after cardiac procedures are common and contribute to increased healthcare utilization and costs. Data on 30-day readmissions after transcatheter aortic valve replacement (TAVR) are limited. Methods and Results - Patients undergoing TAVR (International Classification of Diseases-Ninth Revision-CM codes 35.05 and 35.06) between January and November 2013 who survived the index hospitalization were identified in the Nationwide Readmissions Database. Incidence, predictors, causes, and costs of 30-day readmissions were analyzed. Of 12 221 TAVR patients, 2188 (17.9%) were readmitted within 30 days. Length of stay >5 days during index hospitalization (hazard ratio [HR], 1.47; 95% confidence interval [CI], 1.24-1.73), acute kidney injury (HR, 1.23; 95% CI, 1.05-1.44), >4 Elixhauser comorbidities (HR, 1.22; 95% CI, 1.03-1.46), transapical TAVR (HR, 1.21; 95% CI, 1.05-1.39), chronic kidney disease (HR, 1.20; 95% CI, 1.04-1.39), chronic lung disease (HR, 1.16; 95% CI, 1.01-1.34), and discharge to skilled nursing facility (HR, 1.16; 95% CI, 1.01-1.34) were independent predictors of 30-day readmission. Readmissions were because of noncardiac causes in 61.8% of cases and because of cardiac causes in 38.2% of cases. Respiratory (14.7%), infections (12.8%), bleeding (7.6%), and peripheral vascular disease (4.3%) were the most common noncardiac causes, whereas heart failure (22.5%) and arrhythmias (6.6%) were the most common cardiac causes of readmission. Median length of stay and cost of readmissions were 4 days (interquartile range, 2-7 days) and $8302 (interquartile range, $5229-16 021), respectively. Conclusions - Thirty-day readmissions after TAVR are frequent and are related to baseline comorbidities, TAVR access site, and post-procedure complications. Awareness of these predictors can help identify and target high-risk patients for interventions to reduce readmissions and costs.

Original languageEnglish (US)
Article numbere004472
JournalCirculation: Cardiovascular Interventions
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Keywords

  • aortic stenosis
  • costs and cost analysis
  • length of stay
  • readmission
  • rehospitalization
  • transcatheter aortic valve implantation
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Thirty-Day Readmissions after Transcatheter Aortic Valve Replacement in the United States: Insights from the Nationwide Readmissions Database'. Together they form a unique fingerprint.

Cite this